Posaconazole is a triazole antifungal medication used to prevent and treat serious fungal infections, especially in immunocompromised individuals, and is available under the brand name Noxafil among others. It is grouped under the following drug class(es): QTc-prolonging agents. Its therapeutic use is listed as anti-infectives, antifungals and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Noxafil and posaconazol. Its PubChem CID is 468595.
Posaconazole
| CAS No | 171228-49-2 |
|---|---|
| Molecular Formula | C37H42F2N8O4 |
| Molecular Weight | 700.8 g/mol |
| Synonyms | 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Posaconazole is a triazole antifungal medication used to prevent and treat serious fungal infections, especially in immunocompromised individuals, and is available under the brand name Noxafil among others.
The listed CAS number is 171228-49-2.
The listed molecular formula is C37H42F2N8O4.
The listed molecular weight is 700.8 g/mol.
4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one.
The source lists Noxafil and posaconazol.